María Abad-Fernández
- Virology top 2%
- HIV Research and Treatment 19
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 10
- HIV/AIDS Research and Interventions 7
- Emergency Medicine top 5%
-
- Immune Cell Function and Interaction 8
- T-cell and Retrovirus Studies 6
-
- Animal Disease Management and Epidemiology 5
-
- Mosquito-borne diseases and control 3
-
- Hepatitis C virus research 3
- Co-authors
- Alejandro VallejoSantiago MorenoLaura DíazNadia MadridBeatriz Hernández‐NovoaFernando DrondaCarolina GutiérrezMaría Ángeles Muñoz‐Fernández
- Partner nations
- SpainUnited StatesPhilippines
In The Last Decade
María Abad-Fernández
30 papers receiving 563 citations
Peers
Comparison fields: 5 of 61
- Virology 393
- Infectious Diseases 272
- Emergency Medicine 122
- Immunology 197
- Epidemiology 159
Countries citing papers authored by María Abad-Fernández
This map shows the geographic impact of María Abad-Fernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Abad-Fernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Abad-Fernández more than expected).
Fields of papers citing papers by María Abad-Fernández
This network shows the impact of papers produced by María Abad-Fernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Abad-Fernández. The network helps show where María Abad-Fernández may publish in the future.
Co-authorship network
The 25 scholars most cited alongside María Abad-Fernández, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 6 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 4 | |
| 5 | 2019 | 14 | |
| 6 | 2018 | 17 | |
| 7 | 2015 | 5 | |
| 8 | 2015 | 4 | |
| 9 | 2014 | 5 | |
| 10 | 2014 | 14 | |
| 11 | 2013 | 9 | |
| 12 | 2013 | 44 | |
| 13 | 2013 | 5 | |
| 14 | 2012 | 62 | |
| 15 | 2011 | 82 | |
| 16 | 2011 | 13 | |
| 17 | 2010 | 13 | |
| 18 | 2006 | 2 | |
| 19 | 2004 | 1 | |
| 20 | 2001 | 11 |
About María Abad-Fernández
María Abad-Fernández is a scholar working on Virology, Immunology and Infectious Diseases, having authored 31 papers that have together received 569 indexed citations. Recurring topics across this work include HIV Research and Treatment (19 papers), HIV/AIDS drug development and treatment (10 papers), Immune Cell Function and Interaction (8 papers), HIV/AIDS Research and Interventions (7 papers), T-cell and Retrovirus Studies (6 papers), Animal Disease Management and Epidemiology (5 papers), Mosquito-borne diseases and control (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Virology (393 citations), Infectious Diseases (272 citations) and Emergency Medicine (122 citations). María Abad-Fernández has collaborated with scholars based in Spain, United States and Philippines. Frequent co-authors include Alejandro Vallejo, Santiago Moreno, Laura Díaz, Nadia Madrid, Beatriz Hernández‐Novoa, Fernando Dronda, Carolina Gutiérrez, María Ángeles Muñoz‐Fernández, Javier Zamora and Maria Jesús Pérez‐Elías. Their work appears in journals such as Nature Communications, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.